Aurinia Pharmaceuticals (AUPH) Operating Income (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Operating Income of $41.4 million for Q1 2026, up 24.62% on a QoQ basis from $33.2 million in Q4 2025, and up 89.6% year-over-year from $21.8 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Operating Income (2019 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Operating Income history runs 8 years deep, the most recent figure standing at $41.4 million for Q1 2026.
- Quarterly Operating Income rose 89.6% year-over-year to $41.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $124.5 million (up 309.33% YoY) and the FY2025 annual result came in at $104.9 million, up 2338.4% from the prior year.
- Operating Income was $41.4 million for Q1 2026 at Aurinia Pharmaceuticals, up from $33.2 million in the prior quarter.
- Across five years, Operating Income topped out at $41.4 million in Q1 2026 and bottomed at -$37.9 million in Q1 2022.
- A 5-year average of -$3.6 million and a median of -$9.5 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income sank 71.21% — and 2025, when it surged 2091.55%.
- Aurinia Pharmaceuticals' Operating Income stood at -$28.1 million in 2022, then decreased by 5.6% to -$29.7 million in 2023, then jumped by 94.38% to -$1.7 million in 2024, then jumped by 2091.55% to $33.2 million in 2025, then rose by 24.62% to $41.4 million in 2026.
- Business Quant data shows AUPH's Operating Income at $41.4 million in Q1 2026, $33.2 million in Q4 2025, and $29.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 41.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.42 Mn |
| Dec 31, 2025 | 33.24 Mn |
| Sep 30, 2025 | 29.75 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 21.85 Mn |
| Dec 31, 2024 | -1.67 Mn |
| Sep 30, 2024 | 11.75 Mn |
| Jun 30, 2024 | -1.51 Mn |
| Mar 31, 2024 | -13.25 Mn |
| Dec 31, 2023 | -29.67 Mn |
| Sep 30, 2023 | -16.26 Mn |
| Jun 30, 2023 | -16.17 Mn |
| Mar 31, 2023 | -29.58 Mn |
| Dec 31, 2022 | -28.10 Mn |
| Sep 30, 2022 | -9.50 Mn |
| Jun 30, 2022 | -35.99 Mn |
| Mar 31, 2022 | -37.88 Mn |
| Dec 31, 2021 | -32.71 Mn |
| Sep 30, 2021 | -50.35 Mn |
| Jun 30, 2021 | -47.13 Mn |